Clinical trial
hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle
NCT00398229 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00398229 |
|---|---|
| Title | hCG Supplementation in Frozen-Thawed Embryo Transfer Cycle |
| Official title | The Benefit of Human Chorionic Gonadotropin (hCG) Supplementation Throughout the Secretory Phase of Frozen-Thawed Embryo Transfer Cycles |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fertility Agents, Female |
| Intervention type | Drug |
| Interventions | s.c. human chorionic gonadotropin (Ovitrelle) |
| Enrollment | 300 |
| Start date | Nov 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Nov 10, 2006 |
| Last update posted | Jan 1, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: